Intuitive Surgical Q3 2024 Earnings: Robust Growth Amid Market Challenges
Key Factors to Watch as da Vinci V Expansion Continues Intuitive Surgical (ISRG) has reported strong third-quarter financial results for ...
Tag: analyst
Study Highlights the Life-Saving Potential of Obesity Drugs and Strengthens the Bullish Case for Viking Therapeutics
VKTX’s Innovative Drug Candidates Could Unlock Significant Value for Patients and Investors A recent study has shone new light on ...
Larimar Therapeutics: Targeting the Root Cause of Friedreich’s Ataxia with Nomlabofusp
Biotech company poised to lead FA treatment with innovative protein replacement therapy Larimar Therapeutics (LRMR) has emerged as a promising ...
Coinbase Navigates Market Revival as Stablecoin Market Cap Surges
The crypto exchange raises estimates for Q3 2024 amid stablecoin market recovery and regulatory optimism The cryptocurrency landscape has undergone ...
AMD’s Growth Outlook: AI Prospects Rise, but Market Challenges Loom
Server Share Gains and AI Expansion Counterbalance Gaming and PC Sector Weakness Advanced Micro Devices (AMD) is set to announce ...
SoFi Strikes $2 Billion Deal with Fortress Investment to Expand Personal Loan Business
Strategic Partnership Marks a Major Step in Diversifying Revenue Sources SoFi Technologies (SOFI), an online bank with a vision of ...
Nvidia’s Stock Surges as Blackwell Chip Production Reignites Investor Confidence
AI Leadership and Strong Demand Drive Growth Projections Nvidia's (NVDA) stock is making a strong comeback, climbing 13% this month ...
Upstart Upgraded to Neutral as Improving Credit Quality and Lower Rates Drive Positive Outlook
Better Loan Performance and Diversified Funding Set the Stage for a Stronger 2H’24 Upstart Holdings (UPST), a company known for ...
Affirm Holdings Upgraded to Neutral as Lower Interest Rates Brighten Outlook
Reduced Funding Costs and GMV Growth to Bolster the Buy Now, Pay Later Pioneer Shares of Affirm Holdings (AFRM), a ...
CATX Showcases Breakthroughs in Radiopharmaceutical Development at Oppenheimer Summit
Targeted radiopharmaceuticals promising multiple catalysts and clinical advancements heading into 2024 CATX (CATX), a company pioneering targeted radiopharmaceutical therapies, provided ...
